Symptomatic mucocutaneous toxicity of hydroxyurea in Philadelphia chromosome-negative myeloproliferative neoplasms the mister hyde face of a safe drug
- Latagliata, R
- Spadea, A
- Cedrone, M
- Di Giandomenico, J
- De Muro, M
- Villiva, N
- Breccia, M
- Anaclerico, B
- Porrini, R
- Spirito, F
- Rago, A
- Avvisati, G
- Alimena, G
- Montanaro, M
- Andriani, A
- Volpicelli, P
- Ferretti, A
- Mazzucconi, Mg
- Annino, L
- Felici, S
- Montefusco, E
- Majolino, I
- Trape, G
- Pessina, G
- Cotroneo, E
- Abruzzese, E
- Cimino, G.
- LO COCO, FRANCESCO
Publication date
January 2012
DOIAbstract
The current study was conducted to evaluate severe mucocutaneous toxicity during treatment with hydroxyurea (HU) in a large cohort of patients with Philadelphia chromosome-negative myeloproliferative neoplasms (MPN)
Add to ORKG